Quest Diagnostics (DGX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 480 |
| % of all portfolios: | 0.017% |
| Hold Price * : | $212.00 |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
| Q2  2026 | |||||
| ≡ | Christopher Davis - Davis Advisors | Reduce 3.84% | 62,201 | 0.06 | |
| ≡ | Steven Check - Check Capital Management | Sell 100.00% | 1,300 | 0.02 | |
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 2,756 | 0.01 | |
| Q1  2026 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 88.47% | 21,139 | 0.08 | |
| ≡ | First Eagle Investment Management | Reduce 23.76% | 935 | 0.00 | |
| Q3  2025 | |||||
| ≡ | First Eagle Investment Management | Reduce 32.68% | 1,862 | 0.00 | |
| Q2  2025 | |||||
| ≡ | Christopher Davis - Davis Advisors | Reduce 43.29% | 1,033,882 | 0.99 | |
| ≡ | Sarah Ketterer - Causeway Capital Management | Sell 100.00% | 120,400 | 0.43 | |
| Q1  2025 | |||||
| ≡ | Sarah Ketterer - Causeway Capital Management | Reduce 60.46% | 184,081 | 0.66 | |
| ≡ | Christopher Davis - Davis Advisors | Reduce 0.37% | 8,958 | 0.01 | |
| ≡ | Steven Check - Check Capital Management | Reduce 9.41% | 135 | 0.00 | |
| Q4  2024 | |||||
| ≡ | Sarah Ketterer - Causeway Capital Management | Reduce 10.99% | 37,579 | 0.13 | |
| ≡ | Christopher Davis - Davis Advisors | Reduce 0.08% | 1,843 | 0.00 | |
| Q3  2024 | |||||
| ≡ | Sarah Ketterer - Causeway Capital Management | Reduce 28.16% | 134,056 | 0.53 | |
| ≡ | Steven Check - Check Capital Management | Reduce 25.38% | 488 | 0.01 | |
| Q2  2024 | |||||
| ≡ | Steven Check - Check Capital Management | Reduce 98.58% | 133,522 | 1.39 | |
| ≡ | Sarah Ketterer - Causeway Capital Management | Reduce 4.99% | 25,001 | 0.10 | |
| Q1  2024 | |||||
| ≡ | Christopher Davis - Davis Advisors | Reduce 10.70% | 285,401 | 0.21 | |
| Q3  2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 8,046 | 0.02 | |
| Q2  2023 | |||||
| ≡ | Christopher Davis - Davis Advisors | Reduce 0.32% | 4,864 | 0.00 | |
| Q1  2023 | |||||
| ≡ | Christopher Davis - Davis Advisors | Reduce 17.27% | 317,071 | 0.30 | |
| Q4  2022 | |||||
| ≡ | Christopher Davis - Davis Advisors | Reduce 1.89% | 35,337 | 0.04 | |
| ≡ | First Eagle Investment Management | Reduce 8.36% | 25 | 0.00 | |
| Q3  2022 | |||||
| ≡ | Christopher Davis - Davis Advisors | Reduce 0.99% | 18,655 | 0.02 | |
| Q2  2022 | |||||
| ≡ | Christopher Davis - Davis Advisors | Reduce 2.94% | 57,243 | 0.05 | |
| Q1  2022 | |||||
| ≡ | Christopher Davis - Davis Advisors | Reduce 2.97% | 59,570 | 0.04 | |
| Q4  2021 | |||||
| ≡ | Christopher Davis - Davis Advisors | Reduce 26.84% | 736,328 | 0.59 | |
| Q3  2021 | |||||
| ≡ | Christopher Davis - Davis Advisors | Reduce 2.58% | 72,658 | 0.05 | |
| Q2  2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 2,441 | 0.00 | |
| Q1  2021 | |||||
| ≡ | Christopher Davis - Davis Advisors | Reduce 5.12% | 149,852 | 0.08 | |
| Q4  2020 | |||||
| ≡ | Christopher Davis - Davis Advisors | Reduce 21.84% | 818,355 | 0.47 | |
| Q3  2020 | |||||
| ≡ | Christopher Davis - Davis Advisors | Reduce 3.31% | 128,261 | 0.08 | |
| Q1  2020 | |||||
| ≡ | Christopher Davis - Davis Advisors | Reduce 0.96% | 37,629 | 0.02 | |
| Q4  2016 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 37,510 | 0.04 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.